{
    "clinical_study": {
        "@rank": "104339", 
        "arm_group": [
            {
                "arm_group_label": "15 mm Pyloric balloon dilatation.", 
                "arm_group_type": "Sham Comparator", 
                "description": "During fluoroscopic control the pneumatic balloon is positioned of the pyloric sphincter and maintained there during the entire dilatation."
            }, 
            {
                "arm_group_label": "Pneumatic pyloric dilatation.", 
                "arm_group_type": "Active Comparator", 
                "description": "Endoscopy and 15 mm balloon dilatation is completed according to the same principle as active comparator arm."
            }
        ], 
        "brief_summary": {
            "textblock": "Delayed emptying of the gastric tube after esophagectomy is a frequent and durable problem.\n      No treatment is currently available. It can be hypothesized that incomplete relaxation of\n      the pyloric sphincter may be a significant contributing factor. Pneumatic dilatation may\n      therefore be a potentially effective treatment."
        }, 
        "brief_title": "Pylorus Dysfunction After Esophagectomy and Gastric Tube Reconstruction. Effect of Pneumatic Pylorus Dilatation During Hospital Stay, Surgical Complications During in Hospital Stay", 
        "completion_date": {
            "#text": "December 2015", 
            "@type": "Anticipated"
        }, 
        "condition": [
            "Esophagectomy", 
            "No Signs of Cancer Recurrence", 
            "Delayed Gastric Emptying"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Recurrence", 
                "Gastroparesis"
            ]
        }, 
        "detailed_description": {
            "textblock": "Patients surviving one year after esophagectomy are sent questionnaires to pick up symptoms\n      suggestive of delayed gastric emptying.Those fulfilling predefined criteria for delayed\n      gastric emptying will be invited to the study. The study design is sham controlled single\n      blind with a follow up extending to twelve months post treatment."
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Previous esophagectomy and gastric tube reconstruction.\n\n          -  Symptoms suggestive of delayed gastric emptying.\n\n          -  signed informed consent\n\n        Exclusion Criteria:\n\n          -  Signs of recurrent cancer disease\n\n          -  no symptoms suggestive of delayed gastric emptying.\n\n          -  unwillingness to participate"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "N/A", 
            "minimum_age": "N/A"
        }, 
        "enrollment": {
            "#text": "40", 
            "@type": "Anticipated"
        }, 
        "firstreceived_date": "March 11, 2014", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT02086461", 
            "org_study_id": "2013/896-31/4", 
            "secondary_id": "2013/896-31/4"
        }, 
        "intervention": [
            {
                "arm_group_label": "Pneumatic pyloric dilatation.", 
                "intervention_name": "Pneumatic pyloric dilatation", 
                "intervention_type": "Device"
            }, 
            {
                "arm_group_label": "15 mm Pyloric balloon dilatation.", 
                "intervention_name": "15 mm pyloric balloon dilatation", 
                "intervention_type": "Other"
            }
        ], 
        "is_fda_regulated": "No", 
        "lastchanged_date": "March 12, 2014", 
        "location": {
            "contact": {
                "email": "jon.tsai@ki.se", 
                "last_name": "Jon Tsai, Ass Professor", 
                "phone": "0046858582307"
            }, 
            "contact_backup": {
                "email": "lars.lundell@karolinska.se", 
                "last_name": "Lars Lundell, Professor", 
                "phone": "00468585800000"
            }, 
            "facility": {
                "address": {
                    "city": "Stockholm", 
                    "country": "Sweden", 
                    "zip": "14186"
                }, 
                "name": "Karolinska University Hospital"
            }, 
            "investigator": [
                {
                    "last_name": "Jon Tsai, Ass Professor", 
                    "role": "Principal Investigator"
                }, 
                {
                    "last_name": "lars Lundell, Professor", 
                    "role": "Sub-Investigator"
                }
            ], 
            "status": "Not yet recruiting"
        }, 
        "location_countries": {
            "country": "Sweden"
        }, 
        "number_of_arms": "2", 
        "official_title": "Pylorus Dysfunction After Esophagectomy. Effect of Pneumatic Dilatation.", 
        "overall_contact": {
            "email": "jon.tsai@ki.se", 
            "last_name": "Jon Tsai, Associate professor", 
            "phone": "0046736995364"
        }, 
        "overall_contact_backup": {
            "email": "lars.lundell@karolinska.se", 
            "last_name": "Lars Lundell, Professor", 
            "phone": "0046858500000"
        }, 
        "overall_official": {
            "affiliation": "Karolinska University Hospital, Gastrocentrum", 
            "last_name": "Jon Tsai, ass professor", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Not yet recruiting", 
        "oversight_info": {
            "authority": "Sweden: Regional Ethical Review Board", 
            "has_dmc": "No"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "December 2014", 
            "@type": "Anticipated"
        }, 
        "primary_outcome": {
            "description": "Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation.", 
            "measure": "Symptoms suggestive of delayed gastric emptying", 
            "safety_issue": "No", 
            "time_frame": "3-12 months after treatment"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT02086461"
        }, 
        "responsible_party": {
            "investigator_affiliation": "Karolinska University Hospital", 
            "investigator_full_name": "Lars Lundell", 
            "investigator_title": "Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": [
            {
                "description": "Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation.", 
                "measure": "Quality of Life", 
                "safety_issue": "No", 
                "time_frame": "3-12 months after treatment."
            }, 
            {
                "description": "Symptoms will be assessed at 3, 6 and 12 months after therapy. In case of failure the code will be broken and if sham procedure has been done the patient will be offered pneumatic dilatation. Paracetamol  test done only 3 months after treatment.", 
                "measure": "Delayed gastric emptying", 
                "safety_issue": "No", 
                "time_frame": "3, 6 and 12 months after treatment."
            }
        ], 
        "source": "Karolinska University Hospital", 
        "sponsors": {
            "collaborator": [
                {
                    "agency": "Lund University Hospital", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Sahlgrenska University Hospital, Sweden", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital \u00d6rebro", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "Akademiska Uppsala", 
                    "agency_class": "Other"
                }, 
                {
                    "agency": "University Hospital, Linkoeping", 
                    "agency_class": "Other"
                }
            ], 
            "lead_sponsor": {
                "agency": "Karolinska University Hospital", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "April 2014", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Single Group Assignment, Masking: Single Blind (Subject), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "March 2014"
    }
}